Baisong Mei is the Chief Medical Officer of City Therapeutics. He brings 25 years of industry experience and a strong track record of bringing innovative medicines through clinical development to regulatory approval.

Dr. Mei is a co-inventor of JIVI® and ALTUVIIIO and has led clinical development for multiple new molecular entities including siRNAs, gene therapies, proteins, and small molecules.

Prior to joining City, Dr. Mei was the Executive Vice President and Chief Medical Officer at Editas Medicine and previously Senior Global Project Head in Rare Disease and Rare Blood Disorders at Sanofi. Before joining Sanofi, he served as Therapeutic Area Head for Hematology Clinical Development at Biogen and, earlier in his career, worked in drug discovery research and chemistry, manufacturing and control development at Biogen and Bayer.

Dr. Mei received a Bachelor of Medicine from Bengbu Medical University, China, a Master of Medicine from Wuhan University School of Medicine, China, and a Ph.D. in Biochemistry and Molecular Biology from the University of Toledo. He held postdoctoral fellowships at the University of California San Francisco and the University of California Berkeley.